Vapotherm Past Earnings Performance
Past criteria checks 0/6
Vapotherm's earnings have been declining at an average annual rate of -18.8%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 10% per year.
Key information
-18.8%
Earnings growth rate
53.6%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 10.0% |
| Return on equity | n/a |
| Net Margin | -102.7% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Vapotherm makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 68 | -69 | 61 | 16 |
| 30 Jun 23 | 66 | -81 | 65 | 17 |
| 31 Mar 23 | 63 | -108 | 68 | 19 |
| 31 Dec 22 | 67 | -113 | 75 | 20 |
| 30 Sep 22 | 70 | -110 | 77 | 20 |
| 30 Jun 22 | 95 | -98 | 89 | 20 |
| 31 Mar 22 | 103 | -72 | 94 | 19 |
| 31 Dec 21 | 113 | -60 | 93 | 18 |
| 30 Sep 21 | 132 | -58 | 99 | 18 |
| 30 Jun 21 | 124 | -57 | 92 | 19 |
| 31 Mar 21 | 139 | -48 | 92 | 19 |
| 31 Dec 20 | 126 | -52 | 89 | 17 |
| 30 Sep 20 | 98 | -47 | 76 | 16 |
| 30 Jun 20 | 78 | -47 | 67 | 14 |
| 31 Mar 20 | 55 | -52 | 60 | 13 |
| 31 Dec 19 | 48 | -51 | 56 | 13 |
| 30 Sep 19 | 47 | -51 | 54 | 12 |
| 30 Jun 19 | 45 | -48 | 51 | 11 |
| 31 Mar 19 | 44 | -47 | 49 | 10 |
| 31 Dec 18 | 42 | -43 | 45 | 9 |
| 30 Sep 18 | 41 | -39 | 42 | 8 |
| 30 Jun 18 | 40 | -37 | 39 | 8 |
| 31 Mar 18 | 38 | -33 | 36 | 8 |
| 31 Dec 17 | 36 | -31 | 34 | 8 |
| 31 Dec 16 | 30 | -23 | 26 | 6 |
Quality Earnings: VA20 is currently unprofitable.
Growing Profit Margin: VA20 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VA20 is unprofitable, and losses have increased over the past 5 years at a rate of 18.8% per year.
Accelerating Growth: Unable to compare VA20's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VA20 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: VA20's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.